NYSE American
KAPA
Kairos Pharma, Ltd.
- Health Care
- Listed 2024
- 1 day
- +18.2%
- 1 month
- +8.3%
- 1 year
- −59.9%
$0.3900 · Mkt cap $8.35M
At the 6 Aug 2026 close
NYSE American
Kairos Pharma, Ltd.
$0.3900 · Mkt cap $8.35M
At the 6 Aug 2026 close
Kairos Pharma, Ltd. trades under the ticker KAPA on NYSE American, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2024. Its market capitalisation is $8.35M. The last closing price was $0.3900, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −59.9%, and +8.3% over the past month. Returns are price returns and exclude dividends.
This page exists because KAPA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.